Medical Oncology
Solid-tumor cancers across the body — breast, lung, digestive, urinary, gynecologic, and more. I tailor treatment to your exact diagnosis and to you as a person, drawing on more than four decades of practice and the latest evidence.
How I approach this
I treat solid tumors across the body, and I tailor every treatment to your exact diagnosis and to you as a person. More than four decades at the bedside have taught me that the latest evidence matters most when it is paired with care that listens.
What I treat
Breast
Breast cancer
One of the cancers I treat most often, at every stage, from a first diagnosis to advanced disease.
Hormone-receptor positive · HER2-positive · Triple-negative · Metastatic
We decide on treatment together, weighing what the tumour biology calls for against the life you want to keep living through it.
Lung & chest
Lung cancer
Modern lung-cancer care has changed completely. Targeted therapy and immunotherapy now offer paths that didn’t exist a few years ago.
Non-small-cell (NSCLC) · Small-cell (SCLC) · EGFR / ALK targeted
Mesothelioma
A rare cancer of the chest lining that needs specialised, experienced management, exactly what I provide.
Digestive
Colorectal cancer
From early, curable disease to advanced cases, with treatment matched to your tumour’s molecular profile.
Stomach & esophageal cancer
Coordinated care with surgery and radiation when needed, so nothing about your plan is left in silos.
Pancreatic cancer
A demanding diagnosis where experience matters. I focus on effective treatment and on protecting your quality of life throughout.
Liver & bile duct cancer
Managed in close coordination with liver specialists, with modern targeted and immune treatments where they fit.
Hepatocellular · Cholangiocarcinoma
Neuroendocrine tumors
Often slow-growing tumours that I manage over the long term with targeted, well-tolerated therapies.
Genitourinary
Prostate cancer
Often slow-moving and very manageable, and we’ll match how aggressively to treat to how the disease actually behaves.
Bladder cancer
Treated at every stage, with immunotherapy now a powerful option for many patients.
Kidney cancer
Modern targeted and immune therapies have transformed outcomes, even in advanced disease.
Renal cell carcinoma
Testicular cancer
One of the most curable cancers. Even when advanced, the outlook is usually excellent.
Gynecologic
Ovarian cancer
Treated with surgery and chemotherapy in close partnership, and increasingly with targeted maintenance therapy.
Uterine & endometrial cancer
Frequently caught early and highly treatable, with care tailored to the tumour’s features.
Cervical cancer
Treated with coordinated chemotherapy and radiation, with strong results when addressed promptly.
Head, neck & skin
Head & neck cancer
Complex cancers I treat alongside surgeons and radiation oncologists, with a focus on preserving function.
Oral · Throat · Larynx
Thyroid cancer
Usually very treatable with an excellent long-term outlook, managed in step with endocrine and surgical care.
Melanoma
Advanced skin cancer where immunotherapy has been transformative. Outcomes today are far better than they once were.
Other
Sarcoma
Rare cancers of bone and soft tissue that call for specialised, coordinated treatment.
Bone · Soft tissue
Brain & CNS tumors
Managed in close coordination with neurosurgery and radiation, caring for both the tumour and your daily function.
Cancer of unknown primary
When the origin isn’t clear, I use detailed testing to find the best-matched treatment rather than leaving you in limbo.
Talks and papers on this
- Liquid biopsy as a tool for KRAS/NRAS/BRAF baseline testing in metastatic colorectal cancer
Clinics and Research in Hepatology and Gastroenterology · 2024
- Early breast cancer detection: awareness lecture with Professor Nizar Bitar (October campaign)
Facebook · Sahel General Hospital · 2023
- Professor Nizar Bitar explains colon cancer
YouTube · SAID NGO · 2023
- Diagnosis and management of patients with stage III non-small cell lung cancer: A joint statement by the Lebanese Society of Medical Oncology and the Lebanese Pulmonary Society
Oncology Letters · 2023
- Lung cancer screening in Lebanon: Joint statement from the Lebanese Pulmonary Society and the Lebanese Society of Medical Oncology
World Academy of Sciences Journal · 2023
- Breast cancer awareness tips from Professor Nizar Bitar
Facebook · Sahel General Hospital · 2022
- Incidence of BRAF V600E Gene Mutation Among Lebanese Population in Melanoma and Colorectal Cancer: A Retrospective Study Between 2010 and 2019
Cureus · 2022
- The first Middle East and North Africa expert consensus recommendations for the management of advanced colorectal cancer
Future Oncology · 2022
- Overcoming Therapy Resistance in Colon Cancer by Drug Repurposing
Cancers · 2022
- Early breast cancer detection campaign & awareness lecture by Professor Nizar Bitar (Women’s Advancement Association)
YouTube · Nabatieh TV · 2021
- Large cell neuroendocrine carcinoma of the colon with brain metastasis: A case report
International Journal of Surgery Case Reports · 2020
- Dermatomyositis: A Presenting Clinical Vignette in a Patient With Breast Cancer
Cureus · 2020
- A Case Report: First Report of a Primary Breast Leiomyosarcoma with Lymph Node Metastasis in Lebanon
International Journal of Clinical Research · 2020
- Management of patients with high-risk and advanced prostate cancer in the Middle East: resource-stratified consensus recommendations
World Journal of Urology · 2019
- Prevalence of EGFR and ALK Mutations in Lung Adenocarcinomas in the Levant Area — a Prospective Analysis
Asian Pacific Journal of Cancer Prevention · 2017
- Expression of eukaryotic initiation factor 4E and 4E binding protein 1 in colorectal carcinogenesis
International Journal of Clinical and Experimental Pathology · 2015
- A phase II study of lipoplatin (liposomal cisplatin)/vinorelbine combination in HER-2/neu-negative metastatic breast cancer
Clinical Breast Cancer · 2011
- A clinical phase II study of a non-anthracycline sequential combination of cisplatin-vinorelbine followed by docetaxel as first-line treatment in metastatic breast cancer
Oncology · 2006
- A clinical phase II study of cisplatinum and vinorelbine (PVn) in advanced breast carcinoma (ABC)
American Journal of Clinical Oncology · 2005
- Tamoxifen and endometrial pathologies: A prospective study
Gynecologic Oncology · 1999
Frequently Asked Questions
- How soon can I be seen after a new cancer diagnosis?
- We know a new cancer diagnosis feels urgent and frightening, so we make every effort to see new patients quickly, usually within a few days. When you book, let us know it’s a new diagnosis and we’ll prioritise your appointment.
- Where is treatment such as chemotherapy or infusions given?
- Consultations take place at the main clinic in Zaarour Center, and treatments such as chemotherapy, immunotherapy or infusions are given in the hospital’s day-care unit under Professor Bitar’s supervision, with the nursing team beside you. He also consults at Khoury Hospital. Keeping everything connected means your care stays consistent from visit to visit.
- Do you give second opinions on a diagnosis or a treatment plan started elsewhere?
- Yes. Professor Bitar regularly reviews diagnoses and treatment plans begun elsewhere, whether you’d like reassurance that you’re on the right path or a fresh look at the options. Bring your existing reports and he’ll go through them with you carefully and explain what he would advise.